Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
1.
Laryngoscope ; 2024 May 22.
Artículo en Inglés | MEDLINE | ID: mdl-38775212

RESUMEN

OBJECTIVES/HYPOTHESIS: The pathophysiology of cholesteatoma is not precisely understood, and research on the associated microRNAs (miRNAs) is also deficient. We demonstrated the expression of miRNA in normal skin and middle ear cholesteatoma by next-generation sequencing (NGS) technology. The profiles of miRNA and relevant molecular interaction pathways were investigated. STUDY DESIGN: Case-control experimental study. METHODS: Middle ear cholesteatoma and post-auricular skin tissue specimens were collected from 13 adult patients. Total RNA was extracted, and miRNA expression profiles were analyzed by NGS technology. Functional gene classification to predict target genes and relevant biological pathways was performed using DIANA-microT-CDS and the Kyoto Encyclopedia Gene and Genome database (KEGG) pathways. RESULTS: The expression of 2588 miRNAs from middle ear cholesteatoma and skin tissue samples was analyzed. The expression of 76 upregulated and 128 downregulated miRNAs was identified in the cholesteatoma samples compared to normal skin (FC ≥2 and p < 0.05). Ninety-nine differentially expressed miRNAs (FC ≥4 and p < 0.05) were used to explore the biological pathways involved in the etiopathogenesis of cholesteatoma. The most predicted pathway in cholesteatoma in the upregulated miRNA group was the ErbB signaling pathway and it was extracellular matrix (ECM)-receptor interaction in the downregulated miRNA group. CONCLUSIONS: This was the first study investigating small miRNAs in human acquired cholesteatoma using NGS technique. We were able to identify new miRNAs and pathways related to cholesteatoma. The results of this study are expected to be helpful in revealing new pathophysiologies of cholesteatoma. LEVEL OF EVIDENCE: N/A Laryngoscope, 2024.

2.
Sci Rep ; 14(1): 3321, 2024 02 09.
Artículo en Inglés | MEDLINE | ID: mdl-38337013

RESUMEN

The optimal treatment for sudden sensorineural hearing loss (SSNHL) is unclear. Hyperbaric oxygen therapy (HBOT) has been suggested as a viable option for treatment of SSNHL as it improves vascular dysfunction. In this study, we evaluated the therapeutic effects of HBOT by retrospectively reviewing the records of 2206 patients with SSNHL. 54 who had received HBOT were selected for the HBOT groups, while 59 age-matched controls who had not were selected for the control groups. The HBOT and control groups were divided into subgroups according to intratympanic steroid (ITS) use. Groups A-D had received oral steroids + HBOT, oral steroids only, oral steroids + ITS + HBOT, and oral steroids + ITS, respectively. Of the 113 SSNHL patients, 21 had diabetes mellitus (DM) (2, 0, 9, and 10 patients in Groups A-D, respectively). There was no notable difference in hearing improvement between patients receiving HBOT and those in the control group. However, among diabetic patients, those who underwent HBOT demonstrated a significant improvement in hearing when compared to the control group. The combination of HBOT and steroids could potentially be beneficial for treating severe to profound SSNHL patients with DM.


Asunto(s)
Diabetes Mellitus , Pérdida Auditiva Sensorineural , Pérdida Auditiva Súbita , Oxigenoterapia Hiperbárica , Humanos , Estudios Retrospectivos , Resultado del Tratamiento , Pérdida Auditiva Súbita/terapia , Diabetes Mellitus/terapia , Oxígeno/uso terapéutico , Esteroides/uso terapéutico
3.
J Pers Med ; 13(8)2023 Jul 27.
Artículo en Inglés | MEDLINE | ID: mdl-37623447

RESUMEN

Positive airway pressure (PAP) is an important treatment tool for patients with moderate and severe obstructive sleep apnea (OSA), and adherence to PAP significantly affects treatment outcomes. Disease severity, adverse effects, and psychosocial factors are known to predict medication adherence. Cephalometric parameters have been reported to positively correlate with upper airway collapse. However, research on the correlation between these cephalometric parameters and PAP adherence remains insufficient. This study aimed to identify this relationship. This study included 185 patients with OSA who were prescribed PAP. Polysomnography (PSG) was performed to diagnose OSA, and paranasal sinus computed tomography (PNS CT) was performed to check for comorbidities of the upper airway. In addition, cephalometric parameters such as the hyoid-posterior nasal spine (H-PNS), posterior nasal spine-mandibular plane (PNS-MP), and hyoid-mandibular plane (H-MP) were measured in the midsagittal and axial CT views. Adherence was evaluated 3-12 months after the PAP prescription. A total of 136 patients were PAP-adherent, and 49 were nonadherent. There were more males in the adherent group and a higher average height in the adherent group. The PSG results showed that the apnea-hypopnea index (AHI), respiratory disturbance index (RDI), oxygen desaturation index (ODI), arousal index (AI), rapid eye movement (REM) AHI, and supine AHI were significantly higher, and the lowest oxygen saturation was lower in the adherent group. In the analysis of covariance (ANCOVA) model adjusted for sex and height, among the cephalometric parameters, H-MP was significantly longer in the adherent group (p = 0.027), and H-PNS showed a longer tendency (p = 0.074). In the logistic regression analysis model, the odds ratio (OR) and 95% confidence intervals (95% CI) of adherence and severe OSA in the third tertile compared to the first tertile of H-MP were 2.93 (1.25-6.86) and 4.00 (1.87-8.56). In the case of H-PNS, they were 2.58 (1.14-5.81) and 4.86 (2.24-10.54), respectively. This study concluded that an inferiorly placed hyoid bone in adult patients is associated with PAP adherence and disease severity.

4.
J Clin Med ; 11(23)2022 Nov 29.
Artículo en Inglés | MEDLINE | ID: mdl-36498648

RESUMEN

BACKGROUND: Ear canal skin is directly attached to bone or cartilage, and is also connected to the eardrum. Acute otitis externa is cellulitis of the ear canal skin and subdermal tissue associated with acute inflammation and variable edema. We characterized the microbiome of the normal ear canal and ear canal with otitis externa. METHODS: In total, 28 samples (14 each from the ear canal skin of patients with acute otitis externa and normal healthy controls) were collected using swabs. DNA extraction and bacterial microbiome analysis via 16S rRNA gene sequencing were performed. RESULTS: The diversity index (mean amplicon sequence variants and Shannon index) were lower in the otitis externa than control group. According to linear discriminant effect size (LEfSe) analysis, a number of taxa differed significantly between the groups. Pseudomonas at the genus level and Staphylococcus warneri at the species level were identified in the otitis externa group. CONCLUSION: Our results show the importance of the microbiome in the pathogenesis of otitis externa and provide a basis for treating acute otitis externa by targeting the microbiome.

5.
PLoS One ; 10(4): e0121287, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25830368

RESUMEN

Genotoxicity testing is an important component of toxicity assessment. As illustrated by the European registration, evaluation, authorization, and restriction of chemicals (REACH) directive, it concerns all the chemicals used in industry. The commonly used in vivo mammalian tests appear to be ill adapted to tackle the large compound sets involved, due to throughput, cost, and ethical issues. The somatic mutation and recombination test (SMART) represents a more scalable alternative, since it uses Drosophila, which develops faster and requires less infrastructure. Despite these advantages, the manual scoring of the hairs on Drosophila wings required for the SMART limits its usage. To overcome this limitation, we have developed an automated SMART readout. It consists of automated imaging, followed by an image analysis pipeline that measures individual wing genotoxicity scores. Finally, we have developed a wing score-based dose-dependency approach that can provide genotoxicity profiles. We have validated our method using 6 compounds, obtaining profiles almost identical to those obtained from manual measures, even for low-genotoxicity compounds such as urethane. The automated SMART, with its faster and more reliable readout, fulfills the need for a high-throughput in vivo test. The flexible imaging strategy we describe and the analysis tools we provide should facilitate the optimization and dissemination of our methods.


Asunto(s)
Drosophila/genética , Pruebas de Mutagenicidad/métodos , Recombinación Genética , Animales , Drosophila/fisiología , Cabello/metabolismo , Procesamiento de Imagen Asistido por Computador , Mutación , Alas de Animales/metabolismo
6.
ACS Comb Sci ; 17(4): 234-8, 2015 Apr 13.
Artículo en Inglés | MEDLINE | ID: mdl-25761285

RESUMEN

A critical step in providing better phosphor solution for white light emitting diode (LED) is to utilize inexpensive silicate phosphors with strong thermal stability. Here, we demonstrate yellow silicate phosphor-embedded glass thick films with a high luminous efficacy of ∼32 lm/W at 200 mA as a nonconventional remote-phosphor approach. The simple screen-printing process of a paste consisting of (Ba,Sr,Ca)2SiO4:Eu²âº phosphor and a low softening point glass creates a planar remote structure on a regular soda lime silicate glass with controllable film thickness and location (top vs bottom) of the phosphor layer. The glass matrix provides promising densification and adhesion with the substrate at the optimal low temperature of 410 °C, with the long-term stability in luminous efficacy over 500 h of operation. The proposed phosphor structure has important implications to overcome current limitations as phosphors.


Asunto(s)
Vidrio , Ensayo de Materiales , Membranas Artificiales , Silicatos/química , Temperatura , Técnicas Químicas Combinatorias , Propiedades de Superficie , Difracción de Rayos X
7.
Bioorg Med Chem Lett ; 24(23): 5473-7, 2014 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-25455487

RESUMEN

We identified a novel class of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine compounds as potent HIV-1 replication inhibitors serendipitously during the process of evaluation of triazolothienopyrimidine (TTPM) compounds. Herein, we report synthesis and biological evaluation of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine compounds using a cell-based full replication assay to identify thienopyrimidines 6 and 30, which could be further utilized as viable lead compounds.


Asunto(s)
VIH-1/efectos de los fármacos , Pirimidinas/química , Descubrimiento de Drogas , Humanos , Relación Estructura-Actividad
8.
Methods Mol Biol ; 1173: 51-8, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24920359

RESUMEN

Endogenous small interfering RNAs (endo-siRNAs) are a newly emerged class of small regulatory RNAs. In Drosophila melanogaster, the production of endo-siRNAs depends on the RNase III enzyme Dicer-2 (Dcr-2). Loss of dcr-2 function reduces the resistance of adult flies to various stresses and shortens their life span. The mutants also exhibit alterations in carbohydrate and lipid metabolism. These findings suggest that the endo-siRNA pathway plays a protective role during exposure to stress and aging in D. melanogaster, possibly by regulating metabolic homeostasis. Here, we describe the methods that were used to discover the phenotypes associated with endo-siRNA deficiency by using dcr-2 null mutants.


Asunto(s)
Proteínas de Drosophila/genética , Drosophila melanogaster/fisiología , ARN Helicasas/genética , ARN Interferente Pequeño/metabolismo , Ribonucleasa III/genética , Animales , Frío , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/química , Drosophila melanogaster/genética , Estrés del Retículo Endoplásmico , Eliminación de Gen , Glucosa/análisis , Glucosa/metabolismo , Hemolinfa/química , Hemolinfa/metabolismo , Longevidad , Estrés Oxidativo , ARN Helicasas/metabolismo , Ribonucleasa III/metabolismo , Estrés Fisiológico , Triglicéridos/análisis , Triglicéridos/metabolismo
9.
PLoS One ; 9(2): e87708, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24498359

RESUMEN

The activities and side effects of 5-lipoxygenase (5-LO) inhibitors can be predicted by identifying their redox mechanisms. In this study, we developed a fluorescence-based method to measure the redox potential of 5-LO inhibitors and compared it to the conventional, absorbance-based method. After the pseudo-peroxidase reaction, the amount of remaining lipid peroxide was quantified using the H2DCFDA (2',7'-dichlorodihydrofluorescein diacetate) fluorescence dye. Our method showed large signal windows and provided comparable redox potential values. Importantly, the redox mechanisms of known inhibitors were accurately measured with the fluorescence assay, whereas the conventional, absorbance-based method showed contradictory results. Our findings suggest that our developed method is a better alternative for classifying the redox potential of 5-LO inhibitors, and the fluorescence assay can be effectively used to study the mechanisms of action that are related to redox cycling.


Asunto(s)
Araquidonato 5-Lipooxigenasa/química , Bioensayo/métodos , Colorantes Fluorescentes/análisis , Inhibidores de la Lipooxigenasa/análisis , Inhibidores de la Lipooxigenasa/química , Relación Dosis-Respuesta a Droga , Fluoresceínas/análisis , Fluorescencia , Humanos , Peróxidos Lipídicos/análisis , Oxidación-Reducción
10.
Mol Cells ; 36(3): 212-8, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24008364

RESUMEN

A total of 140,000 compounds were screened in a targetfree cell-based high throughput assay against HIV-1 infection, and a subset of 81 promising compounds was identified. Secondary screening of these 81 compounds revealed two putative human RNaseH2 inhibitors, RHI001 and RHI002, with IC50 value of 6.8 µM and 16 µM, respectively. RHI002 showed selective activity against human RNaseH2 while RHI001 inhibited HIV-RNaseH, E. coli RNaseH, and human RNaseH1 with IC50 value of 28.5 µM, 7.9 µM, and 31.7 µM, respectively. Kinetic analysis revealed that both inhibitors had non-competitive inhibitor-like properties. Because RNaseH2 is involved in the etiology of Aicardi-Goutier syndrome and has been suggested as an anticancer drug target, small molecule inhibitors modulating its activity would be useful for investigating the cellular function of this molecule.


Asunto(s)
Fármacos Anti-VIH/farmacología , Inhibidores Enzimáticos/farmacología , VIH-1/efectos de los fármacos , Pirimidinas/farmacología , Ribonucleasa H/antagonistas & inhibidores , Tiofenos/farmacología , Fármacos Anti-VIH/química , Enfermedades Autoinmunes del Sistema Nervioso/tratamiento farmacológico , Enfermedades Autoinmunes del Sistema Nervioso/etiología , Línea Celular Tumoral , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/química , Proteínas de Escherichia coli/antagonistas & inhibidores , Células HeLa , Ensayos Analíticos de Alto Rendimiento , Humanos , Estructura Molecular , Malformaciones del Sistema Nervioso/tratamiento farmacológico , Malformaciones del Sistema Nervioso/etiología , Pirimidinas/química , Ribonucleasa H/genética , Ribonucleasa H/metabolismo , Ribonucleasa H del Virus de la Inmunodeficiencia Humana/antagonistas & inhibidores , Ribonucleasas , Tiofenos/química
11.
Nat Med ; 19(9): 1157-60, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23913123

RESUMEN

New therapeutic strategies are needed to combat the tuberculosis pandemic and the spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) forms of the disease, which remain a serious public health challenge worldwide. The most urgent clinical need is to discover potent agents capable of reducing the duration of MDR and XDR tuberculosis therapy with a success rate comparable to that of current therapies for drug-susceptible tuberculosis. The last decade has seen the discovery of new agent classes for the management of tuberculosis, several of which are currently in clinical trials. However, given the high attrition rate of drug candidates during clinical development and the emergence of drug resistance, the discovery of additional clinical candidates is clearly needed. Here, we report on a promising class of imidazopyridine amide (IPA) compounds that block Mycobacterium tuberculosis growth by targeting the respiratory cytochrome bc1 complex. The optimized IPA compound Q203 inhibited the growth of MDR and XDR M. tuberculosis clinical isolates in culture broth medium in the low nanomolar range and was efficacious in a mouse model of tuberculosis at a dose less than 1 mg per kg body weight, which highlights the potency of this compound. In addition, Q203 displays pharmacokinetic and safety profiles compatible with once-daily dosing. Together, our data indicate that Q203 is a promising new clinical candidate for the treatment of tuberculosis.


Asunto(s)
Adenosina Trifosfato/biosíntesis , Complejo III de Transporte de Electrones/antagonistas & inhibidores , Tuberculosis Extensivamente Resistente a Drogas/tratamiento farmacológico , Imidazoles/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Piperidinas/farmacología , Piridinas/farmacología , Animales , Proliferación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Complejo III de Transporte de Electrones/genética , Imidazoles/farmacocinética , Ratones , Ratones Endogámicos BALB C , Piperidinas/farmacocinética , Piridinas/farmacocinética , Ratas , Ratas Sprague-Dawley
12.
PLoS One ; 8(7): e68767, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23874756

RESUMEN

Classical target-based, high-throughput screening has been useful for the identification of inhibitors for known molecular mechanisms involved in the HIV life cycle. In this study, the development of a cell-based assay that uses a phenotypic drug discovery approach based on automated high-content screening is described. Using this screening approach, the antiviral activity of 26,500 small molecules from a relevant chemical scaffold library was evaluated. Among the selected hits, one sulfonamide compound showed strong anti-HIV activity against wild-type and clinically relevant multidrug resistant HIV strains. The biochemical inhibition, point resistance mutations and the activity of structural analogs allowed us to understand the mode of action and propose a binding model for this compound with HIV-1 reverse transcriptase.


Asunto(s)
Antivirales/farmacología , Descubrimiento de Drogas/métodos , Evaluación Preclínica de Medicamentos/métodos , VIH-1/efectos de los fármacos , Sulfonamidas/farmacología , Replicación Viral/efectos de los fármacos , Antivirales/metabolismo , Línea Celular , Supervivencia Celular , Ensayo de Inmunoadsorción Enzimática , VIH-1/enzimología , Ensayos Analíticos de Alto Rendimiento , Humanos , Modelos Biológicos , Unión Proteica , ADN Polimerasa Dirigida por ARN/metabolismo , Bibliotecas de Moléculas Pequeñas , Sulfonamidas/metabolismo
13.
J Cell Biochem ; 114(2): 418-27, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22961661

RESUMEN

RNA interference is a eukaryotic regulatory mechanism by which small non-coding RNAs typically mediate specific silencing of their cognate genes. In Drosophila, the RNase III enzyme Dicer-2 (Dcr-2) is essential for biogenesis of endogenous small interfering RNAs (endo-siRNAs), which have been implicated in regulation of endogenous protein-coding genes. Although much is known about microRNA-based regulatory networks, the biological functions of endo-siRNAs in animals remain poorly understood. We performed gene expression profiling on Drosophila dcr-2 null mutant pupae to investigate transcriptional effects caused by a severe defect in endo-siRNA production, and found 306 up-regulated and 357 down-regulated genes with at least a twofold change in expression compared with the wild type. Most of these up-regulated and down-regulated genes were associated with energy metabolism and development, respectively. Importantly, mRNA sequences of 39% of the up-regulated genes were perfectly complementary to the sequences of previously reported endo-siRNAs, suggesting they may be direct targets of endo-siRNAs. We confirmed up-regulation of five selected genes matching endo-siRNAs and concomitant down-regulation of the corresponding endo-siRNAs in dcr-2 mutant pupae. Most of the potential endo-siRNA target genes were associated with energy metabolism, including the citric acid cycle and oxidative phosphorylation in mitochondria, implying that these are major metabolic processes directly affected by endo-siRNAs in Drosophila. Consistent with this finding, dcr-2 null mutant pupae had lower ATP content compared with controls, indicating that mitochondrial energy production is impaired in these mutants. Our data support a potential role for the endo-siRNA pathway in energy homeostasis through regulation of mitochondrial metabolism.


Asunto(s)
Proteínas de Drosophila , Drosophila melanogaster , Mitocondrias/metabolismo , ARN Helicasas , ARN Interferente Pequeño , Ribonucleasa III , Animales , Regulación hacia Abajo , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/genética , Drosophila melanogaster/metabolismo , Perfilación de la Expresión Génica , Análisis por Micromatrices , Mutación , ARN Helicasas/genética , ARN Helicasas/metabolismo , Interferencia de ARN , ARN Interferente Pequeño/biosíntesis , ARN Interferente Pequeño/genética , Ribonucleasa III/genética , Ribonucleasa III/metabolismo , Regulación hacia Arriba
14.
Bioorg Med Chem Lett ; 23(1): 153-7, 2013 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-23206860

RESUMEN

We identified a novel class of triazolothienopyrimidine (TTPM) compounds as potent HIV-1 replication inhibitors during a high-throughput screening campaign that evaluated more than 200,000 compounds using a cell-based full replication assay. Herein, we report the optimization of the antiviral activity in a cell-based assay system leading to the discovery of aryl-substituted TTPM derivatives (38, 44, and 45), which exhibited significant inhibition of HIV-1 replication with acceptable safety margins. These novel and potent TTPMs could serve as leads for further development.


Asunto(s)
Fármacos Anti-VIH/síntesis química , VIH-1/metabolismo , Pirimidinas/química , Triazoles/química , Fármacos Anti-VIH/química , Fármacos Anti-VIH/farmacología , Línea Celular , Evaluación Preclínica de Medicamentos , VIH-1/efectos de los fármacos , Ensayos Analíticos de Alto Rendimiento , Humanos , Pirimidinas/síntesis química , Pirimidinas/farmacología , Relación Estructura-Actividad , Replicación Viral/efectos de los fármacos
15.
Bioorg Med Chem Lett ; 22(7): 2522-6, 2012 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-22374216

RESUMEN

Following the previous SAR of a novel dihydropyrimidinone scaffold as HIV-1 replication inhibitors a detailed study directed towards optimizing the metabolic stability of the ester functional group in the dihydropyrimidinone (DHPM) scaffold is described. Replacement of the ester moiety by thiazole ring significantly improved the metabolic stability while retaining antiviral activity against HIV-1 replication. These novel and potent DHPMs with bioisosteres could serve as advanced leads for further optimization.


Asunto(s)
Transcriptasa Inversa del VIH/antagonistas & inhibidores , VIH-1/efectos de los fármacos , Pirimidinonas/síntesis química , Inhibidores de la Transcriptasa Inversa/síntesis química , Replicación Viral/efectos de los fármacos , Animales , Línea Celular Tumoral , Estabilidad de Medicamentos , VIH-1/fisiología , Humanos , Microsomas Hepáticos/metabolismo , Modelos Moleculares , Nevirapina/farmacología , Pirimidinonas/farmacología , Ratas , Inhibidores de la Transcriptasa Inversa/farmacología , Relación Estructura-Actividad , Tiazoles/química
16.
Bioorg Med Chem Lett ; 22(5): 2119-24, 2012 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-22305583

RESUMEN

3,4-Dihydropyrimidin-2(1H)-ones (DHPMs) were selected and derivatized through a HIV-1 replication assay based on GFP reporter cells. Compounds 14, 25, 31, and 36 exhibited significant inhibition of HIV-1 replication with a good safety profile. Chiral separation of each enantiomer by fractional crystallization showed that only the S enantiomer retained anti-HIV activity. Compound (S)-40, a novel and potent DHPM analog, could serve as an advanced lead for further development and the determination of the mechanism of action.


Asunto(s)
Fármacos Anti-VIH/química , Fármacos Anti-VIH/farmacología , VIH-1/efectos de los fármacos , Pirimidinonas/química , Pirimidinonas/farmacología , Replicación Viral/efectos de los fármacos , Diseño de Fármacos , Infecciones por VIH/tratamiento farmacológico , Humanos , Estereoisomerismo , Relación Estructura-Actividad
17.
ACS Med Chem Lett ; 3(8): 678-82, 2012 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-24900529

RESUMEN

We identified a novel class of aryl-substituted triazine compounds as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) during a high-throughput screening campaign that evaluated more than 200000 compounds for antihuman immunodeficiency virus (HIV) activity using a cell-based full replication assay. Herein, we disclose the optimization of the antiviral activity in a cell-based assay system leading to the discovery of compound 27, which possessed excellent potency against wild-type HIV-1 (EC50 = 0.2 nM) as well as viruses bearing Y181C and K103N resistance mutations in the reverse transcriptase gene. The X-ray crystal structure of compound 27 complexed with wild-type reverse transcriptase confirmed the mode of action of this novel class of NNRTIs. Introduction of a chloro functional group in the pyrazole moiety dramatically improved hERG and CYP inhibition profiles, yielding highly promising leads for further development.

18.
PLoS One ; 6(11): e26675, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22069462

RESUMEN

Tuberculosis is still a leading cause of death worldwide. The selection and spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem. Recently, two different classes of chemical series, the benzothiazinones (BTZ) and the dinitrobenzamide (DNB) derivatives have been found to be highly active against M. tuberculosis, including XDR-TB strains. The target of BTZs is DprE1 protein which works in concert with DprE2 to form the heteromeric decaprenylphosphoryl-ß-D-ribose 2'-epimerase, involved in Decaprenyl-Phospho-Arabinose (DPA) biosynthesis. Interestingly, it has been shown that the DNBs block the same pathway thus suggesting that both drugs could share the same target. Moreover, in Mycobacterium smegmatis the overexpression of the NfnB nitroreductase led to the inactivation of the BTZs by reduction of a critical nitro-group to an amino-group. In this work several spontaneous M. smegmatis mutants resistant to DNBs were isolated. Sixteen mutants, showing high levels of DNB resistance, exhibited a mutation in the Cys394 of DprE1. Using fluorescence titration and mass spectrometry it has been possible to monitor the binding between DprE1 and DNBs, achieving direct evidence that MSMEG_6382 is the cellular target of DNBs in mycobacteria. Additionally, M. smegmatis mutants having low levels of resistance to DNBs harbor various mutations in MSMEG_6503 gene encoding the transcriptional repressor of the nitroreductase NfnB. By LC/MS analysis it has been demonstrated that NfnB is responsible for DNB inactivation. Taken together, our data demonstrate that both DNB and BTZ drugs share common resistance mechanisms in M. smegmatis.


Asunto(s)
Antibacterianos/uso terapéutico , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Mycobacterium smegmatis/efectos de los fármacos , Racemasas y Epimerasas/antagonistas & inhibidores , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Tuberculosis Resistente a Múltiples Medicamentos/microbiología , Benzamidas/química , Benzamidas/uso terapéutico , Western Blotting , Dominio Catalítico , Cromatografía Liquida , Dinitrobencenos/química , Dinitrobencenos/uso terapéutico , Nitrorreductasas/genética , Nitrorreductasas/metabolismo , ARN Mensajero/genética , Racemasas y Epimerasas/genética , Racemasas y Epimerasas/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Tiazinas/química , Tiazinas/uso terapéutico
19.
FEBS Lett ; 585(19): 3079-85, 2011 Oct 03.
Artículo en Inglés | MEDLINE | ID: mdl-21889502

RESUMEN

Small non-coding RNAs regulate gene expression in a sequence-specific manner. In Drosophila, Dicer-2 (Dcr-2) functions in the biogenesis of endogenous small interfering RNAs (endo-siRNAs). We identified 21 distinct proteins that exhibited a ≥ 1.5-fold change as a consequence of loss of dcr-2 function. Most of these were metabolic genes implicated in stress resistance and aging. dcr-2 Mutants had reduced lifespan and were hypersensitive to oxidative, endoplasmic reticulum, starvation, and cold stresses. Furthermore, loss of dcr-2 function led to abnormal lipid and carbohydrate metabolism. Our results suggest roles for the endo-siRNA pathway in metabolic regulation and defense against stress and aging in Drosophila.


Asunto(s)
Drosophila melanogaster/fisiología , Metabolismo Energético/genética , Homeostasis/genética , Esperanza de Vida , ARN Interferente Pequeño/metabolismo , Estrés Fisiológico/genética , Animales , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Femenino , Masculino , ARN Helicasas/genética , ARN Helicasas/metabolismo , Interferencia de ARN , ARN Interferente Pequeño/genética , Ribonucleasa III/genética , Ribonucleasa III/metabolismo
20.
Mol Cells ; 30(1): 29-36, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20652493

RESUMEN

Hempseed, a rich source of polyunsaturated fatty acids (PUFAs) and phytosterols, has been recognized as a potential therapeutic food used for cardioprotection, preventing platelet aggregation, and improving atopic dermatitis. Although several studies have revealed the physiological benefits of hempseed on a variety of animals, the effects of dietary hempseed intake on animal development are currently unknown. In this study, we evaluated the developmental effects of the addition of hempseed meal (HSM) to the diet of Drosophila. Interestingly, dietary HSM intake was shown to increase the body size of flies by increasing cell numbers, and also truncated the larval period without affecting survival rate or longevity. The oviposition of female flies was also increased by dietary HSM supplementation. Interestingly, the levels of sterols, which are precursors of ecdysone, a molting hormone, were found to be elevated in the larvae fed on HSM. Additionally, the hexane extracts of hempseed mimicked the effects of HSM on growth, developmental timing, and reproduction. Moreover, among the major nonpolar components of HSM, feeding on cholesterol but not PUFA mix or campesterol accelerated pupariation and increased body size. These results indicate that the dietary intake of HSM accelerates both body growth and developmental rates in Drosophila via the stimulation of cell growth and ecdysone synthesis. Additionally, nonpolar components of hempseed, such as cholesterol, might be responsible for the effects of HSM on development and reproduction.


Asunto(s)
Cannabis , Drosophila melanogaster/fisiología , Ácidos Grasos Insaturados/administración & dosificación , Semillas , Esteroles/metabolismo , Animales , Cannabis/química , Procesos de Crecimiento Celular/fisiología , Colesterol/biosíntesis , Dieta , Drosophila melanogaster/crecimiento & desarrollo , Drosophila melanogaster/metabolismo , Ingestión de Alimentos , Femenino , Larva , Masculino , Agregación Plaquetaria/efectos de los fármacos , Semillas/química , Análisis de Supervivencia , Regulación hacia Arriba
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA